Viagra Connect hits UK shelves
This article was originally published in OTC Bulletin & The Rose Sheet
Pfizer is preparing a wide-ranging consumer marketing campaign to support the launch of its Viagra Connect (50mg sildenafil) product in the UK, after the country’s first OTC medicine for erectile dysfunction hit the shelves yesterday.
You may also be interested in...
Pfizer has taken the first steps towards turning its Viagra erectile dysfunction treatment into a pan-European OTC brand by taking advantage of Norway's new "non-prescription medicines with guidance" category to secure the Rx-to-OTC switch of the product. Norway will be the second European market where Viagra is available OTC after the UK switched the drug in 2017.
In this first installment of an exclusive three-part series, global switch expert Dr Natalie Gauld speaks to HBW Insight about what makes a country an attractive environment for switching and highlights those markets leading the way today.
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.